|
Status |
Public on Feb 09, 2015 |
Title |
R14del-CMs AAV6-Luc miRNA |
Sample type |
SRA |
|
|
Source name |
Cardiomyocytes derived from PLN-R41del iPSC cells infected with AAV6-EGFP-miR-luc
|
Organism |
Homo sapiens |
Characteristics |
cell type: iPS-derived cardiomyocytes differentiation stage: Day 30 post-differentiation
|
Extracted molecule |
total RNA |
Extraction protocol |
Cardiomyocytes derived from PLN-R41del iPSC cells were infected with AAV6-EGFP-miR-PLN or AAV6-EGFP-miR-luc as a negative control at an MOI of 1e4. One week after infection, total RNA was extracted using Zymo columns and 2 micrograms were used to generate an RNAseq sequencing library. RNA libraries were prepared for sequencing using standard Illumina protocols
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Data processing |
Read alignment with Star under default configurations Gene raw read counts were determined with Htseq under default conditions Genome_build: hg19
|
|
|
Submission date |
Feb 09, 2015 |
Last update date |
May 15, 2019 |
Contact name |
FRANCESCA STILLITANO |
E-mail(s) |
francesca.stillitano@mssm.edu
|
Phone |
+12128249020
|
Organization name |
Mount Sinai School of Medicine
|
Department |
CARDIOVASCULAR RESEARCH
|
Street address |
1470 Madison Avenue
|
City |
NEW YORK |
State/province |
NY |
ZIP/Postal code |
10029 |
Country |
USA |
|
|
Platform ID |
GPL16791 |
Series (2) |
GSE65761 |
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy [RNA-Seq] |
GSE65763 |
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy |
|
Relations |
BioSample |
SAMN03333465 |
SRA |
SRX869318 |